Clinical Trials Directory

Trials / Completed

CompletedNCT00446563

Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

An Open-label, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Amlodipine in Combination With Valsartan Compared to Losartan in Combination With Hydrochlorothiazide Given for 52 Weeks on the Regression of Left Ventricular Hypertrophy in Patients With Mild to Moderate Hypertension

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Novartis · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the safety and efficacy of amlodipine plus valsartan in patients with hypertension and left ventricular hypertrophy

Conditions

Interventions

TypeNameDescription
DRUGValsartan160 mg film coated tablets taken orally once daily in the morning.
DRUGAmlodipine5 mg or 10 mg tablets taken orally once daily in the morning.
DRUGHydrochlorothiazide12.5 mg or 25 mg tablets taken orally once daily in the morning.
DRUGLosartan100 mg tablets taken orally once daily in the morning.

Timeline

Start date
2007-03-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2007-03-13
Last updated
2011-05-11
Results posted
2011-04-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00446563. Inclusion in this directory is not an endorsement.